Literature DB >> 19066319

Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

Xinjie Zhao1, Andreas Peter, Jens Fritsche, Michaela Elcnerova, Andreas Fritsche, Hans-Ulrich Häring, Erwin D Schleicher, Guowang Xu, Rainer Lehmann.   

Abstract

The oral glucose tolerance test (oGTT) is a common tool to provoke a metabolic challenge for scientific purposes, as well as for diagnostic reasons, to monitor the kinetics of glucose and insulin. Here, we aimed to follow the variety of physiological changes of the whole metabolic pattern in plasma during an oGTT in healthy subjects in a nontargeted reversed-phase ultra performance liquid chromatography coupled to electrospray ionization quadrupole time of flight mass spectrometric metabolomics approach. We detected 11,500 metabolite ion masses/individual. Applying multivariate data analysis, four major groups of metabolites have been detected as the most discriminating oGTT biomarkers: free fatty acids (FFA), acylcarnitines, bile acids, and lysophosphatidylcholines. We found in detail 1) a strong decrease of all saturated and monounsaturated FFA studied during the oGTT; 2) a significant faster decline of palmitoleate (C16:1) and oleate (C18:1) FFA levels than their saturated counterparts; 3) a strong relative increase of polyunsaturated fatty acids in the fatty acid pattern at 120 min; and 4) a clear decrease in plasma C10:0, C12:0, and C14:1 acylcarnitine levels. These data reflect the switch from beta-oxidation to glycolysis and fat storage during the oGTT. Moreover, the bile acids glycocholic acid, glycochenodeoxycholic acid, and glycodeoxycholic acid were highly discriminative, showing a biphasic kinetic with a maximum of a 4.5- to 6-fold increase at 30 min after glucose ingestion, a significant decrease over the next 60 min followed by an increase until the end of the oGTT. Lysophosphatidylcholines were also increased significantly. The findings of our metabolomics study reveal detailed insights in the complex physiological regulation of the metabolism during an oGTT offering novel perspectives of this widely used procedure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066319     DOI: 10.1152/ajpendo.90748.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  69 in total

1.  The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

Authors:  Heba M Ismail; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

Review 2.  The significance of the nuclear farnesoid X receptor (FXR) in β cell function.

Authors:  Martina Düfer; Katrin Hörth; Peter Krippeit-Drews; Gisela Drews
Journal:  Islets       Date:  2012-09-01       Impact factor: 2.694

3.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

4.  Plasma acylcarnitines during insulin stimulation in humans are reflective of age-related metabolic dysfunction.

Authors:  Leslie A Consitt; Timothy R Koves; Deborah M Muoio; Masato Nakazawa; Christopher A Newton; Joseph A Houmard
Journal:  Biochem Biophys Res Commun       Date:  2016-09-28       Impact factor: 3.575

5.  Metabolic changes in serum metabolome in response to a meal.

Authors:  Aahana Shrestha; Elisabeth Müllner; Kaisa Poutanen; Hannu Mykkänen; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

6.  Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits.

Authors:  Xinjie Zhao; Jens Fritsche; Jiangshan Wang; Jing Chen; Kilian Rittig; Philippe Schmitt-Kopplin; Andreas Fritsche; Hans-Ulrich Häring; Erwin D Schleicher; Guowang Xu; Rainer Lehmann
Journal:  Metabolomics       Date:  2010-03-07       Impact factor: 4.290

7.  Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach.

Authors:  Marianna Lucio; Agnes Fekete; Cora Weigert; Brigitte Wägele; Xinjie Zhao; Jing Chen; Andreas Fritsche; Hans-Ulrich Häring; Erwin D Schleicher; Guowang Xu; Philippe Schmitt-Kopplin; Rainer Lehmann
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

8.  Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation.

Authors:  Rainer Lehmann; Xinjie Zhao; Cora Weigert; Perikles Simon; Elvira Fehrenbach; Jens Fritsche; Jürgen Machann; Fritz Schick; Jiangshan Wang; Miriam Hoene; Erwin D Schleicher; Hans-Ulrich Häring; Guowang Xu; Andreas M Niess
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

9.  Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.

Authors:  Min Xu; Qibin Qi; Jun Liang; George A Bray; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Circulation       Date:  2013-02-27       Impact factor: 29.690

10.  Metabolomics applied to diabetes research: moving from information to knowledge.

Authors:  James R Bain; Robert D Stevens; Brett R Wenner; Olga Ilkayeva; Deborah M Muoio; Christopher B Newgard
Journal:  Diabetes       Date:  2009-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.